Pelthos Therapeutics Inc. (PTHS)
$20.29+3.94%Close
SELLCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $13M
- Beta
- 3.11
- P/E (TTM)
- -0.48
- Short % float
- 78.24%
- Days to cover
- 4.1
- SI change
- +11.6%
- 1W
- -5.54%
- 1M
- -7.52%
- vs SPY 1W
- -5.40%
- vs SPY 1M
- -10.03%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PTHS?
- LOPJLB’s latest quantitative signal on Pelthos Therapeutics Inc. (PTHS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PTHS in?
- Pelthos Therapeutics Inc. (PTHS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Pelthos Therapeutics Inc. (PTHS) do?
- Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primary offerings include ZELSUVMI, a medication specifically indicated for the treatment of molluscum contagiosum in individuals aged one year and older. Furthermore, the company leverages NITRICIL, an …